Monday – March 20
Earnings watch – Notable companies due to report include Foot Locker (FL). The retailer will also hold an Investor Day event to discuss long-term strategic priorities, growth initiatives, and financial objectives. Options trading implies a 12% move for shares of Foot Locker following the festivities.
Healthcare watch – The FDA action date arrives for both Cidara Therapeutics’s (CDTX) Rezafungin CD101 and Incyte’s (INCY) Ruxolitinib extended release. Both stocks have been jolted in the past with developments with those specific drug candidates. Bank of America has pointed to the Muscular Dystrophy Association conference in Dallas next week as potentially significant, with FDA Director Peter Marks expected to speak. The presentations from Fulcrum Therapeutics (FULC), PepGen (PEPG), PTC Therapeutics (PTCT), and Sarepta Therapeutics (SRPT) have been circled as possible share price movers.
Nvidia (NVDA) will host the highly-anticipated GTC event. The four-day event is expected to cover Nvidia’s latest advancements in generative AI, the metaverse, large language models, robotics, cloud computing and more. CEO Jensen Huang will deliver the opening keynote. Shares of Nvidia have rallied in the week following its GTC event in four of the last five years.
All day – Nano Dimension (NNDM) has a highly-contested shareholder meeting scheduled over a proposal to replace four directors, including chairman Yoav Stern.
All day – Norfolk Southern (NSC) will be back on the hot seat again at a State Senate committee hearing in Pennsylvania. Shares of NSC have underperformed rails peers since the derailment in Ohio with a 19% decline.
All day – The Game Developers Conference will take place. The event has generated buzz in the past with announcement on new tech, launch dates, and industry trends.